Atrium Therapeutics, Inc. (RNA)
Latest RNA Insider Trades
Stephanie Kenney - OfficerGrant or award30,000 sh- Stephanie Kenney - OfficerGrant or award60,000 sh
- Steven George Hughes - Officer
About Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
- SAN DIEGO, CA
- 391
- 2026
- XNAS
https://www.aviditybiosciences.comSEC filings for RNA on EDGAR
90-Day SEC Filing Activity
No Form 4 activity for RNA in the last 90 days.
RNA Insider Transactions (Form 4)
1711 Form 4 filings on record, the earliest from Mar 2, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Stephanie Kenney - Officer | Grant or award | Common Stock |
Recent RNA Form 8-K Filings
3RNA Insider Trading - FAQ
What is the latest insider trade for RNA?
Atrium Therapeutics, Inc. (RNA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-22. The full record for RNA runs to 11 Form 4 filings, the earliest from 2026-03-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RNA stock?
No insider purchases of RNA were filed in the last 90 days.
How many insiders are selling RNA stock?
No insider sales of RNA were filed in the last 90 days.
Where can I see RNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks RNA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RNA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add RNA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Stephanie Kenney view on EDGAR
- - Steven George Hughes view on EDGAR
- - Brendan R. Winslow view on EDGAR
- - Kathleen P. Gallagher view on EDGAR
- - Rocio Martin Hoyos view on EDGAR
- - Husam Younis view on EDGAR
- - Sarah Boyce view on EDGAR
- - Carsten Boess view on EDGAR
- - Troy Edward Wilson view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track RNA insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
